ArticleActa pharmacologica Sinica2026
Discovery of a novel dual-target modulator of ULK1 and ERK1/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70/Cav-1/MMPs axis.
Min-Ru Liao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.